MDWD

Mediwound

• Benzinga·1d ago

  MediWound Showcases New Wound Healing Data Across 3 Global Conferences, EscharEx Study Results Back Late-Stage Trials And Expansion Into Diabetic Ulcers

• Reuters·1d ago

  MediWound presents new EscharEx data backing Phase III VALUE trial in venous leg ulcers

• TipRanks·2d ago

  Analysts Offer Insights on Healthcare Companies: Simulations Plus (SLP) and Mediwound (MDWD)

• TipRanks·6d ago

  MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid

• TipRanks·6d ago

  MediWound says Vericel awarded ten-year contract valued at up to $197M

• Reuters·6d ago

  MediWound says Vericel wins BARDA contract for NexoBrid worth up to $197 million

• TipRanks·03/30 22:40

  MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus

• Reuters·03/30 21:32

  MediWound announces annual shareholder meeting, issues proxy statement and voting materials

• Reuters·03/25 11:20

  MediWound files Form 3 initial beneficial ownership statement; director Vickie Rae Driver reports 1,910 ordinary shares

• Reuters·03/18 21:35

  MediWound Ltd. files Form 3 initial beneficial ownership statement for CFO Hana Luxenburg Kalfon

• Reuters·03/18 21:34

  MediWound Ltd. files Form 3 initial beneficial ownership statement for Chief Medical Officer Ety Klinger

• Reuters·03/18 21:32

  MediWound Ltd. Director David Morton Fox Files Initial Beneficial Ownership Statement

• Reuters·03/18 21:30

  MediWound VP Clinical & Reg. Affairs Ben Yaakov Aya files Form 3 initial beneficial ownership statement

• Reuters·03/18 21:28

  MediWound Ltd. EVP, GC and Corporate Secretary Yaron Meyer files Form 3 initial beneficial ownership statement

• Reuters·03/18 21:25

  MediWound Ltd. Director Stephen T. Wills Files Initial Beneficial Ownership Statement